ADVIL MUSCLE AND JOINT TABLET

Țară: Canada

Limbă: engleză

Sursă: Health Canada

Ingredient activ:

IBUPROFEN

Disponibil de la:

GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC

Codul ATC:

M01AE01

INN (nume internaţional):

IBUPROFEN

Dozare:

400MG

Forma farmaceutică:

TABLET

Compoziție:

IBUPROFEN 400MG

Calea de administrare:

ORAL

Unități în pachet:

15G/50G

Tip de prescriptie medicala:

OTC

Zonă Terapeutică:

OTHER NONSTEROIDAL ANTIIMFLAMMATORY AGENTS

Rezumat produs:

Active ingredient group (AIG) number: 0108883002; AHFS:

Statutul autorizaţiei:

APPROVED

Data de autorizare:

2010-09-02

Caracteristicilor produsului

_ _
_Pfizer Consumer Healthcare, a division of Pfizer Canada ULC _
_Page 1 of 53_
PRODUCT MONOGRAPH
ADVIL
®
TABLETS
ADVIL
®
CAPLETS
ADVIL
® GEL CAPLETS
Ibuprofen Tablets USP, 200 mg
ADVIL
® EXTRA STRENGTH CAPLETS
ADVIL
® MUSCLE AND JOINT
Ibuprofen Tablets USP, 400 mg
ADVIL
®
12 HOUR
Ibuprofen Extended Release Tablets BP, 600 mg
Analgesic/Antipyretic
Pfizer Consumer Healthcare, a division of Pfizer Canada
ULC
450-55 Standish Court
Mississauga, Ontario
L5R 4B2
Date of Preparation:
September 26, 2011
Date of Revision :
October 23, 2019
Submission Control No: 231383
_ _
_Pfizer Consumer Healthcare, a division of Pfizer Canada ULC _
_Page 2 of 53_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................6
ADVERSE REACTIONS
..................................................................................................11
DRUG INTERACTIONS
..................................................................................................16
DOSAGE AND ADMINISTRATION
..............................................................................19
OVERDOSAGE
................................................................................................................20
ACTION AND CLINICAL PHARMACOLOGY
............................................................21
STORAGE AND STABILITY
..........................................................................................23
SPECIAL HANDLING INSTRUCTIONS
.......................................................................23
DOSAGE FORMS, COMPOSITION AND PACKAGING
.........